The rupee’s sharp slide could give IT firms a surprise Q4 bump. This and more in today’s ETtech Top 5.

The Biotechnology Industry Research Assistance Council (BIRAC) launched the fund on February 13 to bridge the funding gap between laborator...

The IXP Lifesciences Catalyst Fund has a greenshoe option of Rs 100 crore with an investment horizon of 3-5 years targeting an IRR of 22 pe...

India's biotechnology sector, valued at USD 150 billion, is expanding, yet innovation and product development potential remain untapped. BI...

So far in 2022, about 63 companies have filed draft papers with Sebi, while 17 companies, including LIC, have raised about ₹41,140 crore fr...

The company provides services to pharmaceutical companies that use artificial intelligence to discover and identify antibodies. Antibody th...

GVRP is being launched with a mission to offer a rather unique “plug and play” model for providing drug discovery services to young biotech...

Various startups are leveraging cutting-edge technologies to revolutionise the way businesses are being carried out across all sectors.

Despite the complexities, long durations and dearth of money required for such research, several young companies are making a global impact...

According to News Corp VCCEdge Healthcare Sector Funding insights, out of the $ 397.41 mn deals so far this year, healthcare startups corne...

A dynamic (as against a set format) education syllabus to support the requirements of the industry for research and development.

Paucity of funding for the Indian biotechnology sector for expanding its operations forces it to look towards mergers and acquisitions, acc...

Vaccines, diagnostics and devices and personalised medicine are the key innovative growth areas for the domestic biotech sector.

India Innovation Fund, best known as the only domestic venture fund that is backed by software services major TCS and telecom leader Airtel...

Nasscom and ICICI Knowledge Park will float the India Innovation Fund with a corpus of Rs 40-45 cr.

Kiran Mazumdar Shaw, Biocon CMD speaks on latest developments within her company and the impact of global financial crisis on the biotechno...

According to the market talk, the promoters of Core Projects had pledged a large number of shares with some non-banking financial companies...